Categories Prevention, Screening
Search Results for Categories Prevention, Screening page 1
Relevance: High
Most relevant for: People concerned about their breast cancer risk who are considering genetic testing to guide breast screening
Study: Genetic testing can help identify who needs high-risk breast screening
Researchers in the WISDOM Study looked at women who had genetic testing and had an inherited mutation in a gene linked to increased breast cancer risk. When only risk factors other than genetic testing were considered, high-risk screening would not have been advised for most of these women. These results highlight how important genetic testing is to identify many women who need additional breast cancer screening. (posted 10/16/2026)
READ MORE ›
Relevance: High
Most relevant for: People with inherited cancer-related genetic mutations and their families
Study: Family communication and genetic testing after an inherited cancer risk is identified
A new study found that most people with an inherited cancer-related gene mutation share their results with family members. However, many relatives never pursue genetic testing. This means some relatives may miss opportunities to learn about their cancer risk and take steps to reduce it through screening, prevention or early detection. (posted 10/1/2026)
READ MORE ›
Relevance: Medium
Most relevant for: People taking or considering GLP-1 drugs
Study: GLP-1 drugs and breast cancer: results from ASCO 2026
Studies presented at the 2026 ASCO Annual Meeting looked at GLP-1 drugs in relation to breast cancer prevention and survival. Across these early studies, people taking GLP-1s drugs often had better breast cancer outcomes than similar people not taking them. (posted 7/20/2026)
READ MORE ›
Relevance: Medium-High
Most relevant for: People at high-risk for colorectal cancer
Study: Comparison of GLP-1 drugs and aspirin for colorectal cancer prevention
This study compared aspirin with GLP-1 drugs used for type 2 diabetes and weight loss to see which might better prevent colorectal cancer in people who had not already had colorectal cancer. Researchers found that people who took GLP-1 drugs were less likely to develop colorectal cancer than those who took aspirin. (posted 6/26/2026)
READ MORE ›
Relevance: Medium-High
Most relevant for: People with a BRCA1 or BRCA2 mutation who have had ovarian cancer
Study: Breast cancer risk after ovarian cancer in women with BRCA mutations
Women who have an inherited mutation in BRCA1 or BRCA2 have a higher lifetime risk of developing breast and ovarian cancer compared to women without these mutations. This study found that after being diagnosed with ovarian cancer, women with a BRCA1 or BRCA2 mutation have a relatively low risk of developing breast cancer. (posted 5/18/2026)
READ MORE ›
Relevance: Medium
Most relevant for: People with Lynch syndrome
Study: Early trial of new vaccine shows promise for people with Lynch syndrome
The Nous-209 vaccine for preventing cancer in people with Lynch syndrome was tested in an early-phase study. The safety and immune response results were encouraging. An immune response was seen in most participants, suggesting that the vaccine may help reduce the chance of developing cancer in people with Lynch syndrome. (posted 3/23/2026)
READ MORE ›
Relevance: Medium-High
Most relevant for: People who have had or are considering liquid biopsy testing
Topic: What patients need to know about liquid biopsies in cancer care
Liquid biopsies are tests that look for signs of cancer in blood or other body fluids. These signs can include cancer cells that have broken away from a tumor, pieces of cancer cell DNA and proteins or other biomarkers found in cancer cells. Liquid biopsies can be used to screen for cancer before a cancer diagnosis or guide treatment after a diagnosis. (posted 2/6/26)
READ MORE ›
Relevance: High
Most relevant for: Men and women diagnosed with breast cancer who have a BRCA1 or BRCA2 mutation
Study: Understanding the risks of a second cancer after a breast cancer diagnosis in people with BRCA1 and BRCA2 mutations
After breast cancer, people who have a BRCA1 or BRCA2 mutation face a greater risk of a second cancer compared to individuals without a BRCA mutation. This study helps to better understand this risk so that breast cancer survivors with mutations can receive informed, personalized plans for surveillance and follow-up care. (Posted 12/11/25)
READ MORE ›
Relevance: Medium-High
Most relevant for: Women with a BRCA1 or BRCA2 mutation who have a uterus.
Study: Endometrial cancer risk for people with BRCA1 and BRCA2 mutations
This study looked at how often endometrial cancer occurred in people with BRCA1 or BRCA2 mutations to better understand how BRCA mutations affect the risk of endometrial cancer. The researchers also asked whether known risk factors for endometrial cancer impact the frequency of endometrial cancer in people with BRCA1 or BRCA2 mutations. Findings from the study highlight the importance of shared conversations between patients and providers regarding risk monitoring and preventive options. (posted 10/7/25)
READ MORE ›
Relevance: High
Most relevant for: Families with a known MLH1 mutation
Study: Cancer may occur at earlier ages in later generations of families with Lynch syndrome
In families with Lynch syndrome mutations, cancer may occur at an earlier age with each generation. This study looked at the effect called anticipation in families with MLH1-associated Lynch syndrome. (Posted 10/3/25)
READ MORE ›